Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Noemie Cresto"'
Autor:
Sophie Sakkaki, Noemie Cresto, Raphaël Chancel, Maé Jaulmes, Emma Zub, Marine Blaquière, Pierre Sicard, Tangui Maurice, Sandrine Ellero-Simatos, Laurence Gamet-Payrastre, Nicola Marchi, Julie Perroy
Publikováno v:
Environment International, Vol 180, Iss , Pp 108201- (2023)
The omnipresence of environmental contaminants represents a health danger with ramifications for adverse neurological trajectories. Here, we tested the dual-hit hypothesis that continuous exposure to non-observable adverse effect level (NOAEL) glypho
Externí odkaz:
https://doaj.org/article/ec621fdd13bc4c01a42a4701c968b3eb
Autor:
Valentin Garcia, Marine Blaquiere, Alicia Janvier, Noemie Cresto, Carla Lana, Athenais Genin, Helene Hirbec, Etienne Audinat, Adele Faucherre, Emmanuel L. Barbier, Sophie Hamelin, Philippe Kahane, Chris Jopling, Nicola Marchi
Publikováno v:
Neurobiology of Disease, Vol 187, Iss , Pp 106297- (2023)
Mechanosensors are emerging players responding to hemodynamic and physical inputs. Their significance in the central nervous system remains relatively uncharted. Using human-derived brain specimens or cells and a pre-clinical model of mesio-temporal
Externí odkaz:
https://doaj.org/article/c1415310d3054dd4ace2dd6dec496b9a
Autor:
Noemie Cresto, Nicolas Lebrun, Florent Dumont, Franck Letourneur, Pierre Billuart, Nathalie Rouach
Publikováno v:
Cells, Vol 11, Iss 9, p 1545 (2022)
Oligophrenin-1 (OPHN1) is a Rho-GTPase-activating protein (RhoGAP), whose mutations are associated with X-linked intellectual disability (XLID). OPHN1 is enriched at the synapse in both pre- and postsynaptic compartments, where it regulates the RhoA/
Externí odkaz:
https://doaj.org/article/82f78e576c574eeba9b402b2ade55fc9
Autor:
Solene Micou, Isabel Forner-Piquer, Noemie Cresto, Tess Zassot, Aurélien Drouard, Marianne Larbi, Matteo E. Mangoni, Etienne Audinat, Chris Jopling, Adèle Faucherre, Nicola Marchi, Angelo G. Torrente
Publikováno v:
Environmental Technology & Innovation. :103196
Autor:
Noemie Cresto, Isabel Forner-Piquer, Asma Baig, Mousumi Chatterjee, Julie Perroy, Jacopo Goracci, Nicola Marchi
Publikováno v:
Chemosphere. 324:138251
Autor:
Diana M. Dincã, Louison Lallemant, Anchel González-Barriga, Noémie Cresto, Sandra O. Braz, Géraldine Sicot, Laure-Elise Pillet, Hélène Polvèche, Paul Magneron, Aline Huguet-Lachon, Hélène Benyamine, Cuauhtli N. Azotla-Vilchis, Luis E. Agonizantes-Juárez, Julie Tahraoui-Boris, Cécile Martinat, Oscar Hernández-Hernández, Didier Auboeuf, Nathalie Rouach, Cyril F. Bourgeois, Geneviève Gourdon, Mário Gomes-Pereira
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-18 (2022)
Myotonic dystrophy type 1 (DM1) is characterized by debilitating neurological symptoms. Dinca et al. demonstrate the pronounced impact of DM1 on the morphology and RNA metabolism of astrocytes. Their findings suggest astroglial pathology in DM1 brain
Externí odkaz:
https://doaj.org/article/b8326071658541fb95db0b3ac8971f3d
Autor:
Diana M. Dincã, Louison Lallemant, Anchel González-Barriga, Noémie Cresto, Sandra O. Braz, Géraldine Sicot, Laure-Elise Pillet, Hélène Polvèche, Paul Magneron, Aline Huguet-Lachon, Hélène Benyamine, Cuauhtli N. Azotla-Vilchis, Luis E. Agonizantes-Juárez, Julie Tahraoui-Bories, Cécile Martinat, Oscar Hernández-Hernández, Didier Auboeuf, Nathalie Rouach, Cyril F. Bourgeois, Geneviève Gourdon, Mário Gomes-Pereira
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-1 (2022)
Externí odkaz:
https://doaj.org/article/38ea75853dc34e0c869d60f3421b8a42
Autor:
Noémie Cresto, Marie-Claude Gaillard, Camille Gardier, Francesco Gubinelli, Elsa Diguet, Déborah Bellet, Laurine Legroux, Julien Mitja, Gwenaëlle Auregan, Martine Guillermier, Charlène Josephine, Caroline Jan, Noëlle Dufour, Alain Joliot, Philippe Hantraye, Gilles Bonvento, Nicole Déglon, Alexis-Pierre Bemelmans, Karine Cambon, Géraldine Liot, Emmanuel Brouillet
Publikováno v:
Neurobiology of Disease, Vol 134, Iss , Pp - (2020)
The G2019S substitution in the kinase domain of LRRK2 (LRRK2G2019S) is the most prevalent mutation associated with Parkinson's disease (PD). Neurotoxic effects of LRRK2G2019S are thought to result from an increase in its kinase activity as compared t
Externí odkaz:
https://doaj.org/article/f99d8776c12c4a7bb6880f866319890e
Autor:
Noémie Cresto, Camille Gardier, Marie-Claude Gaillard, Francesco Gubinelli, Pauline Roost, Daniela Molina, Charlène Josephine, Noëlle Dufour, Gwenaëlle Auregan, Martine Guillermier, Suéva Bernier, Caroline Jan, Pauline Gipchtein, Philippe Hantraye, Marie-Christine Chartier-Harlin, Gilles Bonvento, Nadja Van Camp, Jean-Marc Taymans, Karine Cambon, Géraldine Liot, Alexis-Pierre Bemelmans, Emmanuel Brouillet
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 13, p 6760 (2021)
Alpha-synuclein (α-syn) and leucine-rich repeat kinase 2 (LRRK2) play crucial roles in Parkinson’s disease (PD). They may functionally interact to induce the degeneration of dopaminergic (DA) neurons via mechanisms that are not yet fully understoo
Externí odkaz:
https://doaj.org/article/22c7a6ea143b4f2585dbefbd517cfee2